DOI QR코드

DOI QR Code

Helicobacter pylori Infection에 관한 합성의약품 대비 한약의 효과에 대한 체계적 문헌고찰: PubMED를 중심으로

Systematic Review of the Effects of Herbal Medicine Versus Synthetic Drugs on Helicobacter Pylori Infection

  • 조은지 (상지대학교 한의과대학) ;
  • 정설 (상지대학교 한의과대학) ;
  • 곽승연 (상지대학교 한의과대학) ;
  • 정의민 (상지대학교 한의학과 내과학교실)
  • Cho, Eun Ji (College of Korean Medicine, Sangji University) ;
  • Jeong, Seol (College of Korean Medicine, Sangji University) ;
  • Gwak, Seung Yeon (College of Korean Medicine, Sangji University) ;
  • Jerng, Ui Min (Department of Korean Internal Medicine, College of Korean Medicine, Sangji University)
  • 투고 : 2021.08.09
  • 심사 : 2021.10.06
  • 발행 : 2021.11.30

초록

Objective : This systematic review was conducted to investigate the effect of herbal medicine on Helicobacter pylori(H. pylori) infection compared to amoxicillin included synthetic drugs. Methods : Relevant randomized controlled trials(RCTs) which were published prior to December 26, 2020, were collected using PubMED database. Risk of bias evaluation and data extraction were done independently by two reviewers, and the third reviewer reassessed mismatching parts. Results : Two RCTs testing two different herbal medicines against synthetic drugs solitary treatment or synthetic drugs with placebo for herbal medicine were included. One study reported that there was no significant difference between the eradication rate of synthetic drugs and the herbal medicine. The other study did not report the eradication rate of the herbal medicine. One study reported histologic severity, the other reported dyspepsia score as efficacy indicators. There was no adverse event reported in all studies. However, the number of included RCTs was too small, the quality of reported data was not enough to verify efficacy of herbal medicine, and there were some methodological problems. Conclusion : It was difficult to conclude that solitary treatment of herbal medicine was as effective as amoxicillin included synthetic drugs for H. pylori infection.

키워드

과제정보

이 연구는 보건복지부의 지원을 받아 보건산업진흥원 과제(HF20C0002)의 지원을 받아 수행되었습니다.

참고문헌

  1. Jung HK, Kang SJ, Lee YC, Yang HJ, Park SY, Shin CM, et al. Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea 2020. Gut and liver. 2021. 15(2): p. 168-195. https://doi.org/10.5009/gnl20288
  2. Kim JH, Do EJ,L GS. Investigation of Anti-microbial Activity of Herbal Medicines Used as NaturalPreservatives Based on the Analysis of Papers and Patents. J Physiol &Pathol Korean Med. 2015. 29(1): p. 101-113. https://doi.org/10.15188/kjopp.2015.02.29.1.101
  3. Lee JJ, Kim SH, Chang BS, Lee JB, Huh CS, Kim TJ, et al. The antimicrobial activity of medicinal plants extracts against Helicobacter pylori. Korean journal of food science and technology. 1999. 31(3): p. 764-770.
  4. Cho YJ, Ju IS, Kim BO, Kim JH, Lee BG, An BJ, et al. The antimicrobial activity against Helicobacter pylori and antioxidant effect from the extracts of mulberry leaves (Morus alba L.). Applied Biological Chemistry. 2007. 50(4): p. 334-343.
  5. Park SH, Kim DK,B JH. The antioxidant effect of Portulaca oleracea extracts and its antimicrobial activity on Helicobacter pylori. The Korean Journal of Food And Nutrition. 2011. 24(3): p. 306-311. https://doi.org/10.9799/KSFAN.2011.24.3.306
  6. Kwon SO, Kwak DY, Hong SP, Kim WH, Park JM, Han YM, et al. Randomized, Double-blind, Placebo-controlled Clinical Trial for the Evaluation of the Efficacy and Safety of Artemisia and Green Tea Extract SD1003F in Volunteers with Helicobacter pylori-associated Gastric Discomfort. The Korean Journal of Helicobacter and Upper Gastrointestinal Research. 2018. 18(1): p. 38-49. https://doi.org/10.7704/kjhugr.2018.18.1.38
  7. Kim DK, Lee JA, Kim YB, Lee KM,H KB. A randomized controlled trial assessing Korea red ginseng treatment of Helicobacter pylori-associated chronic gastritis. The Korean Journal of Medicine. 2007. 72(1): p. 20-28.
  8. Lee SH,K SM. Eradication of Helicobacter pylori by licorice extract: a case report. Journal of Korean Institute for Functional Medicine. 2020. 3: p. 31-35. https://doi.org/10.32581/jkifm.2020.3.1.31
  9. Gail MH, You WC, Chang YS, Zhang L, Blot WJ, Brown LM, et al. Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data. Control Clin Trials. 1998. 19(4): p. 352-69. https://doi.org/10.1016/S0197-2456(98)00016-6
  10. You WC, Zhang L, Gail MH, Ma JL, Chang YS, Blot WJ, et al. Helicobacter pylori infection, garlic intake and precancerous lesions in a Chinese population at low risk of gastric cancer. Int J Epidemiol. 1998. 27(6): p. 941-4. https://doi.org/10.1093/ije/27.6.941
  11. Gail MH,Y WC. A factorial trial including garlic supplements assesses effect in reducing precancerous gastric lesions. J Nutr. 2006. 136(3 Suppl): p. 813-815.
  12. You WC, Brown LM, Zhang L, Li JY, Jin ML, Chang YS, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst. 2006. 98(14): p. 974-83. https://doi.org/10.1093/jnci/djj264
  13. Gail MH, Pfeiffer RM, Brown LM, Zhang L, Ma JL, Pan KF, et al. Garlic, vitamin, and antibiotic treatment for Helicobacter pylori: a randomized factorial controlled trial. Helicobacter. 2007. 12(5): p. 575-8. https://doi.org/10.1111/j.1523-5378.2007.00528.x
  14. Asif HM, Zaidi SF, Sugiyama T, Akhtar N,U K. Phytomedicine-based and Quadruple Therapies in Helicobacter pylori Infection: A Comparative, Randomized Trial. Altern Ther Health Med. 2015. 21 Suppl 2: p. 33-9.
  15. Dixon MF, Genta RM, Yardley JH,C P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996. 20(10): p. 1161-81. https://doi.org/10.1097/00000478-199610000-00001
  16. Lam, SK,NJ Talley. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol. 1998. 13(1): p. 1-12. https://doi.org/10.1111/j.1440-1746.1998.tb00537.x
  17. O'Gara EA, Maslin DJ, Nevill AM,H DJ. The effect of simulated gastric environments on the anti-Helicobacter activity of garlic oil. J Appl Microbiol. 2008. 104(5): p. 1324-31. https://doi.org/10.1111/j.1365-2672.2007.03637.x
  18. Canizares P, Gracia I, Gomez LA, Martin de Argila C, Boixeda D, Garcia A, et al. Allylthiosulfinates, the bacteriostatic compounds of garlic against Helicobacter pylori. Biotechnol Prog. 2004. 20(1): p. 397-401. https://doi.org/10.1021/bp034143b
  19. Cellini L, Di Campli E, Masulli M, Di Bartolomeo S,A N. Inhibition of Helicobacter pylori by garlic extract (Allium sativum). FEMS Immunol Med Microbiol. 1996. 13(4): p. 273-7. https://doi.org/10.1016/0928-8244(95)00120-4
  20. Ayala G, Escobedo-Hinojosa WI, de la Cruz-Herrera CF,R I. Exploring alternative treatments for Helicobacter pylori infection. World J Gastroenterol. 2014. 20(6): p. 1450-69. https://doi.org/10.3748/wjg.v20.i6.1450
  21. Iimuro M, Shibata H, Kawamori T, Matsumoto T, Arakawa T, Sugimura T, et al. Suppressive effects of garlic extract on Helicobacter pylori-induced gastritis in Mongolian gerbils. Cancer Lett. 2002. 187(1-2): p. 61-8. https://doi.org/10.1016/S0304-3835(02)00401-9
  22. Canizares P, Gracia I, Gomez LA, Garcia A, Martin De Argila C, Boixeda D, et al. Thermal degradation of allicin in garlic extracts and its implication on the inhibition of the in-vitro growth of Helicobacter pylori. Biotechnol Prog. 2004. 20(1): p. 32-7. https://doi.org/10.1021/bp034135v
  23. van der Hulst RW, Keller JJ, Rauws EA,T GN. Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter. 1996. 1(1): p. 6-19. https://doi.org/10.1111/j.1523-5378.1996.tb00003.x
  24. Salmanroghani H, Mirvakili M, Baghbanian M, Salmanroghani R, Sanati G,Y P. Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial. PLOS ONE. 2018. 13(6): p. e0197096. https://doi.org/10.1371/journal.pone.0197096
  25. Zheng Q, Pan Y, Zhang L,X SD. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection. Chin J Dig Dis. 2005. 6(4): p. 202-5. https://doi.org/10.1111/j.1443-9573.2005.00233.x
  26. Mahady GB, Pendland SL, Stoia A, Hamill FA, Fabricant D, Dietz BM, et al. In vitro susceptibility of Helicobacter pylori to botanical extracts used traditionally for the treatment of gastrointestinal disorders. Phytother Res. 2005. 19(11): p. 988-91. https://doi.org/10.1002/ptr.1776
  27. O'Mahony R, Al-Khtheeri H, Weerasekera D, Fernando N, Vaira D, Holton J, et al. Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World J Gastroenterol. 2005. 11(47): p. 7499-507. https://doi.org/10.3748/wjg.v11.i47.7499
  28. Nostro A, Cellini L, Di Bartolomeo S, Cannatelli MA, Di Campli E, Procopio F, et al. Effects of combining extracts (from propolis or Zingiber officinale) with clarithromycin on Helicobacter pylori. Phytother Res. 2006. 20(3): p. 187-90. https://doi.org/10.1002/ptr.1830
  29. Siddaraju MN,D SM. Inhibition of gastric H+, K+-ATPase and Helicobacter pylori growth by phenolic antioxidants of Zingiber officinale. Mol Nutr Food Res. 2007. 51(3): p. 324-32. https://doi.org/10.1002/mnfr.200600202
  30. Siddaraju MN,D SM. Inhibition of gastric H(+),K(+)-ATPase and Helicobacter pylori growth by phenolic antioxidants of Curcuma amada. J Agric Food Chem. 2007. 55(18): p. 7377-86. https://doi.org/10.1021/jf070719r
  31. Sarkar A, De R,M AK. Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases. World J Gastroenterol. 2016. 22(9): p. 2736-48. https://doi.org/10.3748/wjg.v22.i9.2736
  32. Woo JH, Park JM, Jang JH, Yang H, Surh YJ,N HK. Curcumin induces expression of 15-hydroxyprostaglandin dehydrogenase in gastric mucosal cells and mouse stomach in vivo: AP-1 as a potential target. J Nutr Biochem. 2020. 85: p. 108469. https://doi.org/10.1016/j.jnutbio.2020.108469
  33. Mahady GB, Pendland SL, Yun G,L ZZ. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Anticancer Res. 2002. 22(6c): p. 4179-81.
  34. Wittschier N, Faller G,H A. Aqueous extracts and polysaccharides from liquorice roots (Glycyrrhiza glabra L.) inhibit adhesion of Helicobacter pylori to human gastric mucosa. J Ethnopharmacol. 2009. 125(2): p. 218-23. https://doi.org/10.1016/j.jep.2009.07.009
  35. Fukai T, Marumo A, Kaitou K, Kanda T, Terada S,N T. Anti-Helicobacter pylori flavonoids from licorice extract. Life Sci. 2002. 71(12): p. 1449-63. https://doi.org/10.1016/S0024-3205(02)01864-7
  36. Zaidi SF, Yoshida I, Butt F, Yusuf MA, Usmanghani K, Kadowaki M, et al. Potent bactericidal constituents from Mallotus philippinensis against clarithromycin and metronidazole resistant strains of Japanese and Pakistani Helicobacter pylori. Biol Pharm Bull. 2009. 32(4): p. 631-6. https://doi.org/10.1248/bpb.32.631